European Institute of Science AB Logo

European Institute of Science AB

Develops and sells diagnostic solutions and instruments for veterinary health.

EURI B | SPGR

Overview

Corporate Details

ISIN(s):
SE0020357440 (+1 more)
LEI:
549300VADF7E2RMTRE02
Country:
Sweden
Address:
Ideongatan 1A, 223 70 Lund

Description

European Institute of Science AB develops, manufactures, and sells diagnostic solutions with a primary focus on veterinary health. The company provides point-of-care instrumentation, such as the TurboReader™ nephelometric analyzer and the Abacus Vet5 hematology analyzer, alongside a portfolio of quantitative immunoassays for canine, feline, and equine markets. These assays detect and monitor key biomarkers like C-reactive protein (CRP), Serum Amyloid A (SAA), and Albumin, and are designed for both its point-of-care systems and large clinical analyzers in central laboratories. The company also functions as a research and development center with a history of creating patent families and founding several public technology companies. Additionally, it distributes veterinary diagnostic products from external manufacturers within Scandinavia.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2009-10-03 20:01 English 33.4 KB
2009-02-11 11:09 Swedish 323.6 KB
2009-02-02 14:29 Swedish 255.8 KB
2008-10-31 09:45 Swedish 328.3 KB
2008-09-30 13:47 Swedish 28.4 KB
2008-08-29 10:36 Swedish 322.1 KB
2008-06-30 08:05 Swedish 259.1 KB
2008-05-16 15:08 Swedish 258.5 KB
2008-04-29 00:00 Swedish 687.0 KB
2008-04-18 12:45 Swedish 45.8 KB
2008-04-14 09:22 Swedish 320.2 KB
2008-01-21 10:46 Swedish 320.6 KB
2007-10-26 08:14 Swedish 322.1 KB
2007-10-16 10:47 Swedish 257.6 KB
2007-08-31 11:52 Swedish 320.1 KB

Automate Your Workflow. Get a real-time feed of all European Institute of Science AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for European Institute of Science AB

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for European Institute of Science AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2024-11-27 Pharmart AB Other Sell 9,341 19,709.51 SEK

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.